期刊文献+

糖皮质激素对SLE患者Th1/Th2类细胞因子mRNA表达及产生的影响 被引量:3

Effects of Glucocorticoids on Th1/Th2 Cytokine Expression in Peripher al Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus
原文传递
导出
摘要 目的探讨糖皮质激素治疗对系统性红斑狼疮(SLE)患者外周血单一核细胞(PBMC)中Th1/Th2类细胞因子mRNA表达及产生的影响。方法采用逆转录-聚合酶链反应和酶联免疫吸附试验检测糖皮质激素治疗前后SLE患者PBMC中Th1类细胞因子干扰素γ(IFN-γ)和Th2类细胞因子白介素4(IL-4)、白介素10(IL-10)mRNA表达和产生的变化。结果经糖皮质激素治疗后SLE患者PBMC产生IFN-γ,IL-4和IL-10水平分别为(74.08±15.85)pg/mL,(246.43±45.25)pg/mL,(549.52±67.00)pg/mL;mRNA平均表达水平分别为0.3298±0.2181,0.4951±0.2938,0.8671±0.6620。治疗前IFN-γ,IL-4和IL-10水平分别为(113.5±27.6)pg/mL,(272.97±33.78)pg/mL,(625.32±104.61)pg/mL;mRNA平均表达水平分别为1.4094±0.6317,0.6872±0.4713,1.1758±0.6255;治疗后各细胞因子水平均较治疗前显著降低(P<0.01);但IFN-γ较IL-4,IL-10降低更为显著。结论糖皮质激素可通过影响SLE患者细胞因子mRNA表达和产生,调节Th1/Th2类细胞因子网络平衡,可能为糖皮质激素治疗SLE的机制之一。 Objective To investigate the effects of glucocorticoids o n the expression of Th1/Th2 cytokines at mRNA and protein levels in peripheral b lood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SL E). Methods Th1 cytokine (IFN-IL-10) in PBMCs fro m 48 patients with SLE were detected before and after treatment with glucocortic oids by RT-PCR for mRNA expression and ELISA for protein production. The systemi c lupus erythematosus activity measure (SLAM) scores of patients were compared b efore and after treatment. Results After treatment, the expression and product ion of IFN- versus 1.4094 pg/mL; P < 0.01). The reduction of the ex pression of IL-4 and IL-10 was less than that of IFN-At the same time, the SLAM scores after treatment were significantly lower than those before treatment (4.48 Conclusion These res ults support the hypothesis that glucocorticoids may induce a shift from Th1 to Th2 profile of cytokine secretion which might be one of the mechanisms of glucoc orticoid in the treatment of SLE.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2004年第12期706-708,共3页 Chinese Journal of Dermatology
关键词 SLE 糖皮质激素 患者 mRNA表达 TH1/TH2类 IL-4 细胞因子 产生 水平 结论 Lupus erythematosus,systemic Glucocorticoids Lymphocyte C ytokines
  • 相关文献

参考文献5

  • 1Yamamura M, Uyemura K, Deans R J, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science,1991, 254: 277-279.
  • 2谢红付,李捷,施为,陈翔,陈明亮,杜乾君,陈服文.皮质类固醇激素对系统性红斑狼疮患者Th细胞因子平衡的影响[J].湖南医科大学学报,2002,27(6):533-535. 被引量:4
  • 3徐顺明 郑绍同 季晓琪.系统性红斑狼疮患者血清白介素2与Th2细胞因子的检测[J].中华皮肤科杂志,2001,34:58-58.
  • 4Franchimont D, Louis E, Dewe W, et al. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures.Regul Pept, 1998, 73: 59-65.
  • 5Norbiato G, Bevilacqua M, Vago T, et al. Glucocorticoids and Th-1,Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma,atopic dermatitis and AIDS. Clin Exp Rheumatol, 1997, 15: 315-323.

二级参考文献8

  • 1Bombardier C, Gladman DD, Urowitz MB,et al. Derivation of the SLEDAI A Disease Activity Index for Lupus Patients[J]. Arthritis Rhumatism, 1992,35:630-639.
  • 2Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted protieins[J]. J Immunol, 1986,136:2348-2357.
  • 3Wong CK, Ho CY,Li EK,et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and TH2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosous[J]. Lupus, 2001,9:589-593.
  • 4Viallard JF, Pellegrin JL,Ranchin V,et al. Th1(IL-2,interferon-gamma(IFN-γ)) and Th2 (IL-10,IL-4)cytokine production by peripheral blood mononuclear cell (PMBC)from patients with systemic lupus erythematosous (SLE)[J].Clin Exp Immunol,1999;115;189-195.
  • 5Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function [J]. Annu Rev Immunol, 2000,18:309-345.
  • 6Norbiato G,Bevilacqua M, Vago T. Glucocorticoids and Th-1,Th-2type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS[J]. Clin Exp Rheumatoid, 1997, 15:315-323.
  • 7Mysliwiec J,Kretowski A,Toplskal J,et al. Serum Th1and Th2 profile cytokine level changes in patients with Graves Ophthalmopathy treatment with corticosteroids[J].Horm Metab Res, 2001,33:739-743.
  • 8Agarwal SK,Marshall GDJR.Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines[J]. J Interferon Cytokine Res, 2001,21:147-155.

共引文献5

同被引文献21

  • 1李元媛,苏定雷,宣恒报,王慧娟,衡春,李玉峰,季晓辉.霉酚酸及地塞米松对系统性红斑狼疮患者外周血淋巴细胞凋亡的影响[J].南京医科大学学报(自然科学版),2005,25(4):221-223. 被引量:2
  • 2侯芸,王金龙.调节性T细胞、TGF-β与系统性红斑狼疮[J].中国中西医结合皮肤性病学杂志,2005,4(2):127-130. 被引量:6
  • 3张开明,李新华.骨髓与T细胞作用及SLE研究进展[J].长治医学院学报,2005,19(2):158-160. 被引量:2
  • 4郑毅,董馨,陆江阳,赵敏.类风湿关节炎滑膜中高迁移率族蛋白1的表达[J].中华风湿病学杂志,2005,9(11):684-686. 被引量:6
  • 5Dean GS, Tyrrell-Price J, Crawley E, et al. Cytokines and systemic lupus erythematosus. Ann Rheum Dis, 2000, 59: 243-251.
  • 6Carvajal IM, Baron RM, Perrella MA. High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses. Crit Care Med, 2002, 30 Suppl: S36-S42.
  • 7Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum, 2002, 46: 2598-2603.
  • 8Popovie K, Ek M, Espinosa A, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum, 2005, 52: 3639-3645.
  • 9Seaffidi P, Misteli T, Bianchi M. Release of chromatin protein HMGB-1 by necrotic cells triggers inflammation. Nature, 2002, 418: 191-195.
  • 10Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 2000, 192: 565-570.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部